Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Express Scripts Holding Co. (ESRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/20/2018 8-K Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs: "Amended and Restated Certificate of Incorporation of Express Scripts Holding Company",
"Amended and Restated Bylaws of Express Scripts Holding Company",
"Second Supplemental Indenture, by and among Express Scripts Holding Company, Cigna Holding Company (formerly known as Cigna Corporation) and U.S. Bank National Association, as Trustee, to that certain base indenture, by and among Halfmoon Parent, Inc. (now known as Cigna Corporation) and U.S. Bank National Association (as supplemented by that certain first supplemental indenture thereto dated as of September 17, 2018)",
"Additional Guarantor Supplement, by Express Scripts Holding Company and Cigna Holding Company (formerly known as Cigna Corporation) to that certain Revolving Credit and Letter of Credit Agreement, by and among Cigna Corporation (now known as Cigna Holding Company), Halfmoon Parent, Inc. (now known as Cigna Corporation), JPMorgan Chase Bank, N.A., as administrative agent, and the other parties thereto",
"Additional Guarantor Supplement, by Express Scripts Holding Company and Cigna Holding Company (formerly known as Cigna Corporation) to that certain Term Loan Credit Agreement, by and among Cigna Corporation (now known as Cigna Holding Company), Halfmoon Parent, Inc. (now known as Cigna Corporation), Morgan Stanley Senior Funding, Inc., as administrative agent, and the other parties thereto",
"Twenty-Fifth Supplemental Indenture, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Express Scripts Holding Company and Wells Fargo Bank, National Association, as Trustee, to that certain base indenture, by and between Express Scripts Holding Company and Wells Fargo Bank, National Association",
"Ninth Supplemental Indenture, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Express Scripts, Inc. and MUFG Union Bank, N.A. (as successor to Union Bank, N.A.), as Trustee, to that certain base indenture, by and among Express Scripts, Inc., certain subsidiaries of Express Scripts, Inc. and MUFG",
"Second Supplemental Indenture, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Medco Health Solutions, Inc. and U.S. Bank Trust National Association, as Trustee, to that certain base indenture, by and between Medco Health Solutions, Inc. and U.S. Bank Trust National Association",
"Cigna Completes Combination with Express Scripts, Establishing a Blueprint to Transform the Health Care System"
12/19/2018 8-K Regulation FD Disclosure
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : December 19, 2018 EXPRESS SCRIPTS HOLDING COMPANY Delaware 001-35490 45-2884094 File Number) Identification No.) One Express Way, St. Louis, MO 63121 Registrant's telephone number, including area code 314-996-0900 Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act &#974..."
12/13/2018 8-K Regulation FD Disclosure
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : December 13, 2018 EXPRESS SCRIPTS HOLDING COMPANY Delaware 001-35490 45-2884094 File Number) Identification No.) One Express Way, St. Louis, MO 63121 Registrant's telephone number, including area code 314-996-0900 Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act &#974..."
11/21/2018 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Letter Agreement, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc",
"Letter Agreement, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc"
10/31/2018 8-K Quarterly results
Docs: "Express Scripts Announces 2018 Third Quarter Results ST. LOUIS, October 31, 2018 — Express Scripts Holding Company announced consolidated 2018 third quarter net income of $1,071.6 million or $1.89 per diluted share. Consolidated 2018 third quarter adjusted earnings per diluted share were $2.43, which represents growth of 28% over consolidated 2017 third quarter adjusted earnings per diluted share. /1 “Our momentum is strong: we achieve industry-leading drug trend, specialized care for patients and breakthrough pharmacy and healthcare solutions, which have helped us achieve strong client retention and increased interest from prospects. Across the board we are driving strong results, as we did in the third quarter,” said Tim Wentworth, President and CEO. “As we look ahead to our planned comb..."
09/18/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "FORM 8-K",
"U.S. DEPARTMENT OF JUSTICE GRANTS CLEARANCE TO CIGNA'S ACQUISITION OF EXPRESS SCRIPTS"
08/29/2018 8-K Regulation FD Disclosure
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : August 29, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report"
08/24/2018 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Express Scripts Stockholders Approve Acquisition by Cigna ST. LOUIS, Aug. 24, 2018 /PRNewswire/ - Stockholders of Express Scripts Holding Company today approved the proposed acquisition of Express Scripts by Cigna. Based on a preliminary tabulation, approximately 78 percent of the shares of Express Scripts common stock outstanding and entitled to vote adopted the Agreement and Plan of Merger with Cigna and certain of its subsidiaries. These shares represent more than 99 percent of the shares voted at a special meeting of shareholders held earlier today. Earlier today, Cigna announced that its stockholders also adopted the merger agreement. The transaction remains subject to the satisfaction of customary closing conditions, including applicable regulatory approvals. Express Scripts expects ..."
08/13/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Express Scripts Reminds Stockholders to Vote “FOR” the Merger"
08/10/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : August 10, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote “FOR” Merger with Cigna"
08/01/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : August 1, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Express Scripts Announces 2018 Second Quarter Results - Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth - Raises Core Adjusted EBITDA Guidance Range - Increases Client Retention Level - Projects 2% to 3% Core Adjusted Claims Growth for 2019 ST. LOUIS, August 1, 2018 — Express Scripts Holding Company announced consolidated 2018 second quarter net income of $877.3 million or $1.55 per diluted share. Consolidated 2018 second quarter adjusted earnings per diluted share were $2.22, which represents growth of 28% over consolidated 2017 second quarter adjusted earnings per diluted share.* The Company increased its 2018 core business¹ adjusted EBITDA* guidance from a range of $5,250 million to $5,400 million to a range of $5,275 million to $5,425 million, which represents growth of..."
07/02/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment No. 1 to the Agreement and Plan of Merger, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc",
"Amendment No. 1 to the Agreement and Plan of Merger, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc"
05/14/2018 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : May 10, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report"
05/02/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : May 2, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Express Scripts Announces 2018 First Quarter Results ST. LOUIS, May 2, 2018 — Express Scripts Holding Company announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated 2018 first quarter adjusted earnings per diluted share was $1.77.* The Company reaffirms its core business¹ 2018 adjusted EBITDA* guidance in the range of $5,250 million to $5,400 million, which represents growth of 8% over core business 2017 adjusted EBITDA at the midpoint of the range. “Our first quarter results reflect our success in driving greater value for clients, delivering better health outcomes for patients and growth in earnings for shareholders,” said Tim Wentworth, President and CEO. “Express Scripts' focused business model, our innovative solutions and unmat..."
04/25/2018 8-K Quarterly results
04/24/2018 8-K Quarterly results
03/09/2018 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financi...
Docs: "FORM 8-K",
"Agreement and Plan of Merger, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc., and Halfmoon II, Inc",
"Amendment No. 1 to Amended and Restated Bylaws of Express Scripts Holding Company"
03/08/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "CIGNA TO ACQUIRE EXPRESS SCRIPTS FOR $67 BILLION"
02/27/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : February 27, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Express Scripts Announces 2017 Fourth Quarter and Full Year Results ST. LOUIS, February 27, 2018 — Express Scripts Holding Company announced consolidated 2017 fourth quarter and full year net income of $2,327.6 million and $4,517.4 million, respectively, or $4.10 and $7.74 per diluted share, respectively. Consolidated 2017 fourth quarter and full year adjusted earnings per diluted share were $2.16 and $7.10, respectively.* “Throughout 2017, Express Scripts kept our patients and clients ahead of the curve by providing best-in-class solutions. These solutions limited prescription drug spending growth to an average of 1.5% over 2016, a record low, for commercial plans,” said Tim Wentworth, President and CEO. “We have also seen a strong start to 2018, with outstanding client implementations, a..."
01/26/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
12/19/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/30/2017 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : November 30, 2017 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange A...",
"Twenty-Second Supplemental Indenture, among the Company, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as Trustee",
"Twenty-Third Supplemental Indenture, among the Company, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as Trustee and Calculation Agent",
"Twenty-Fourth Supplemental Indenture, among the Company, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as Trustee",
"Opinion Letter of Skadden, Arps, Slate, Meagher & Flom LLP regarding the validity of the Notes"
11/22/2017 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Underwriting Agreement, among the Company, the subsidiary guarantors party thereto and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Citigroup Global Markets Inc. and Mizuho Securities USA LLC, as representatives of the several underwriters named therein"
11/14/2017 8-K Quarterly results
11/03/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K",
"TRANSITION AND RELEASE AGREEMENT ERIC SLUSSER"
10/31/2017 8-K Quarterly results
10/24/2017 8-K Quarterly results
Docs: "Express Scripts Announces 2017 Third Quarter Results ST. LOUIS, October 24, 2017 - Express Scripts Holding Company announced 2017 third quarter net income of $841.7 million or $1.46 per diluted share. 2017 third quarter adjusted earnings per diluted share was $1.90.* “We have taken significant steps forward this year to build upon our heritage of industry leadership, client alignment and quality patient care, all of which positions us for growth,” said Tim Wentworth, President and CEO of Express Scripts. “We are transforming Express Scripts to win for the long term through significant investments in technology, launches of novel solutions that address the country's biggest healthcare challenges, and expanding our role and reach in the broader healthcare market with our agreement to acquire...",
"Express Scripts Appoints James M. Havel Chief Financial Officer"
10/10/2017 8-K Quarterly results
07/25/2017 8-K Form 8-K - Current report:
06/27/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/20/2017 8-K Form 8-K - Current report
05/23/2017 8-K Form 8-K - Current report
05/12/2017 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : May 11, 2017 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report"
04/24/2017 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy